These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17450340)

  • 1. [Vaccines against herpex simplex virus infections. What's new].
    Hoeller Obrigkeit D; Baron JM
    Hautarzt; 2007 May; 58(5):465-6. PubMed ID: 17450340
    [No Abstract]   [Full Text] [Related]  

  • 2. [A killed commercial vaccine against herpes simplex viruses 1 and 2 as an immunocorrective agent in chronic herpetic infection].
    Barinskiĭ IF; Kasparov AA; Lazarenko AA; Alimbarova LM; Davydova AA; Belkina IV; Platonova AL
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):98-102. PubMed ID: 10876868
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of prophylactic vaccines for genital and neonatal herpes.
    Jones CA; Cunningham AL
    Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What's new in vaccines against herpes simplex infections?].
    Bosseray A; Bonadona A; Morand P
    Pathol Biol (Paris); 2002 Oct; 50(8):483-92. PubMed ID: 12469517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trends in antibody prevalence of herpes simplex virus types 1 and 2].
    Osaka M
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():202-9. PubMed ID: 16615468
    [No Abstract]   [Full Text] [Related]  

  • 6. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses.
    Stanfield BA; Kousoulas KG; Fernandez A; Gershburg E
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiology of herpes simplex virus (HSV) infections.
    Corey L
    Herpes; 2001 Mar; 8 Suppl 1():1A. PubMed ID: 11867026
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice.
    Dutton JL; Li B; Woo WP; Marshak JO; Xu Y; Huang ML; Dong L; Frazer IH; Koelle DM
    PLoS One; 2013; 8(10):e76407. PubMed ID: 24098493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant plasmid containing CpG motifs as a novel vaccine adjuvant for immune protection against herpes simplex virus 2.
    He Z; Xu J; Tao W; Fu T; He F; Hu R; Jia L; Hong Y
    Mol Med Rep; 2016 Aug; 14(2):1823-8. PubMed ID: 27357208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large scale comparison of adjuvant effects on immunogenicity and protection in a herpes simplex virus type 1 vaccination model.
    Simms JR; Heath AW; Richardson VJ; Jennings R
    Biochem Soc Trans; 1997 May; 25(2):272S. PubMed ID: 9191316
    [No Abstract]   [Full Text] [Related]  

  • 11. Changing epidemiology of herpes simplex virus infections.
    Whitley RJ
    Clin Infect Dis; 2013 Feb; 56(3):352-3. PubMed ID: 23087393
    [No Abstract]   [Full Text] [Related]  

  • 12. IgG and IgM antibodies of Herpes Simplex Virus type-1 and type-2 in 233 maternal and neonatal sera.
    Dong Z; Li Y; Liu R
    Int J Gynaecol Obstet; 1998 Oct; 63(1):69-70. PubMed ID: 9849717
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential prophylactic and therapeutic vaccines for HSV infections.
    Ramachandran S; Kinchington PR
    Curr Pharm Des; 2007; 13(19):1965-73. PubMed ID: 17627530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a novel serology algorithm to detect herpes simplex virus 1 or 2 antibodies.
    Zahariadis G; Severini A
    Sex Transm Dis; 2010 Nov; 37(11):696-9. PubMed ID: 20693937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The primary immune response and virus-specific and -nonspecific immune complexes in neonatal cytomegalovirus and herpetic infection].
    Vel'tishcheva EIu; Viduta OD; Ponomareva AM; Karakhan NM; Nisan LG; Dement'eva NM; Aleshkin VA
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):104-5. PubMed ID: 8079522
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicentre clinical trial with herpes simplex virus vaccine in recurrent herpes infection.
    Mastrolorenzo A; Tiradritti L; Salimbeni L; Zuccati G
    Int J STD AIDS; 1995; 6(6):431-5. PubMed ID: 8845402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic fatigue and herpes virus antibodies].
    Ewig S
    Dtsch Med Wochenschr; 1994 Sep; 119(38):1296. PubMed ID: 7924923
    [No Abstract]   [Full Text] [Related]  

  • 18. A tale of 2 alpha-herpesviruses: lessons for vaccinologists.
    Rouse BT; Kaistha SD
    Clin Infect Dis; 2006 Mar; 42(6):810-7. PubMed ID: 16477558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibodies to herpes simplex virus types I and II in depressed patients.
    Amsterdam JD; Hernz WJ
    Biol Psychiatry; 1993 Sep; 34(6):417-20. PubMed ID: 8218610
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccines for herpes simplex virus infections.
    Koelle DM
    Curr Opin Investig Drugs; 2006 Feb; 7(2):136-41. PubMed ID: 16499283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.